• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    More On ONXX

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Onyx Pharmaceuticals, Inc. (ONXX)

    -NasdaqGS
    124.70 0.00(0.00%) Sep 30, 4:00PM EDT
    Add to Portfolio
    Prev Close:124.70
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:135.92
    Beta:2.16
    Next Earnings Date:N/A
    Day's Range:N/A - N/A
    52wk Range:68.12 - 136.87
    Volume:0
    Avg Vol (3m):2,834,630
    Market Cap:N/A
    P/E (ttm):N/A
    EPS (ttm):-1.62
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ONXX 0.00%N/A
    AVEOUp 4.94%44.01M
    MRKUp 1.02%169.86B
    NVSUp 0.04%228.83B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-13) :N/A
    Quarterly EPS Est (Sep-13) :N/A
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Onyx Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies that target the molecular mechanisms that cause cancer in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback